Palomar Medical Technologies (NASDAQ: PMTI) is one of 82 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it compare to its peers? We will compare Palomar Medical Technologies to related companies based on the strength of its risk, institutional ownership, valuation, earnings, dividends, profitability and analyst recommendations.
Institutional and Insider Ownership
65.5% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 12.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
This table compares Palomar Medical Technologies and its peers gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Palomar Medical Technologies||N/A||N/A||-49.67|
|Palomar Medical Technologies Competitors||$975.11 million||$120.37 million||300.98|
Palomar Medical Technologies’ peers have higher revenue and earnings than Palomar Medical Technologies. Palomar Medical Technologies is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Volatility and Risk
Palomar Medical Technologies has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500. Comparatively, Palomar Medical Technologies’ peers have a beta of 1.11, meaning that their average stock price is 11% more volatile than the S&P 500.
This table compares Palomar Medical Technologies and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Palomar Medical Technologies||N/A||N/A||N/A|
|Palomar Medical Technologies Competitors||-436.90%||-31.56%||-15.56%|
This is a breakdown of current ratings and price targets for Palomar Medical Technologies and its peers, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Palomar Medical Technologies||0||0||0||0||N/A|
|Palomar Medical Technologies Competitors||271||1320||2795||100||2.61|
As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 5.31%. Given Palomar Medical Technologies’ peers higher probable upside, analysts clearly believe Palomar Medical Technologies has less favorable growth aspects than its peers.
Palomar Medical Technologies peers beat Palomar Medical Technologies on 5 of the 9 factors compared.
About Palomar Medical Technologies
Palomar Medical Technologies, Inc. (Palomar) is a researcher and developer of aesthetic light-based systems for hair removal and other cosmetic procedures, including both lasers and high powered lamps. The Company offers a range of products based on technologies that include, but are not limited to: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing, pseudofolliculitis barbae (PFB) treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, and other skin treatments. In June 2013, Cynosure Inc announced the completion of its acquisition of Palomar Medical Technologies Inc.
Receive News & Ratings for Palomar Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.